爱游戏平台注册登录

We are now two standalone organizations

Life Sciences & Diagnostics and Analytical & Enterprise Solutions

check quantity

IVISbrite Yersinia enterocolitic Xen25 Bioluminescent Bacterial Strain

IVISbrite Yersinia enterocolitica Xen25 bioluminescent bacteria is derived from the parental strain WS2589. For in vitro or in vivo imaging applications, IVISbrite Y. enterocolitica-Xen25 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome.

For research use only. Not for use in diagnostic procedures.

Part Number 119233
Request Technical Support

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

Infectious disease is a perennially important area for both life science research and drug discovery. Some of the first applications of IVIS® imaging technology were in tracking infections and monitoring host responses, and these applications are still at the forefront of research. 爱游戏平台注册登录 's bioluminescent infectious disease light-producing microorganisms have been developed to mimic both acute and chronic standard infection protocols presently used by researchers.

  • Engineered Bacterium: Yersinia enterocolitica - Xen25
  • Parental Strain: WS2589
  • In Vitro/Ex Vivo: Growth profiles
  • In Vivo: Not tested

Advantages of using bioluminescent light-producing microorganisms for drug discovery in vitro:

  • Rapid and readily amenable to high throughput screening, e.g., 96 or 384-well format
  • Sensitivity - subtle changes in cellular viability are rapidly detected
  • Inexpensive - no additional substrates needed for bacterial assays

Advantages of using bioluminescent light-producing microorganisms for drug discovery in vivo:

  • Rapid identification of lead drug candidates
  • Real-time efficacy data
  • May help to decrease drug failure by allowing disease relapse to be monitored in the same animal

Specifications

Gram Positive Gram Negative Gram negative
Luciferase Classification Bacterial luciferase
Optical Imaging Classification Bioluminescence Imaging
Product Brand Name IVISbrite
Shipping Condition Ambient
Therapeutic Area Infectious Diseases
Unit Size 1 agar plate
Resources, Events & More
  • All

Brochure

In Vivo Imaging Reagents

Our comprehensive range of bioluminescent and fluorescent imaging reagents provide researchers with the necessary tools to better understand early disease-related biological changes, track disease progression, help guide the drug discovery process, and evaluate efficacy and safety of drug candida ...

PDF 1 MB

Ebook

In Vivo Imaging Solutions eBook

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And ...

PDF 4 MB

Guide

IVISense™ Fluorescent Probe Selector Guide for Oncology Research

The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.

This s ...

PDF 4 MB

White Paper

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick ...

PDF 547 KB
Baidu
map